![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. Positive Feedback between Transcriptional and Kinase Suppression in Nematodes with Extraordinary Longevity and Stress Resistance 1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America 2Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America 3Central Arkansas Veterans Healthcare Service, Little Rock, Arkansas, United States of America Susan E. Mango, Editor Huntsman Cancer Institute, United States of America #Contributed equally. * E-mail: rjsr/at/uams.edu ¤Current address: Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America Conceived and designed the experiments: ÇT SA RJSR. Performed the experiments: ÇT SA PB. Analyzed the data: SA RJSR. Wrote the paper: RJSR. Received April 14, 2008; Accepted March 11, 2009. Abstract Insulin/IGF-1 signaling (IIS) regulates development and metabolism, and modulates aging, of Caenorhabditis elegans. In nematodes, as in mammals, IIS is understood to operate through a kinase-phosphorylation cascade that inactivates the DAF-16/FOXO transcription factor. Situated at the center of this pathway, phosphatidylinositol 3-kinase (PI3K) phosphorylates PIP2 to form PIP3, a phospholipid required for membrane tethering and activation of many signaling molecules. Nonsense mutants of age-1, the nematode gene encoding the class-I catalytic subunit of PI3K, produce only a truncated protein lacking the kinase domain, and yet confer 10-fold greater longevity on second-generation (F2) homozygotes, and comparable gains in stress resistance. Their F1 parents, like weaker age-1 mutants, are far less robust—implying that maternally contributed trace amounts of PI3K activity or of PIP3 block the extreme age-1 phenotypes. We find that F2-mutant adults have <10% of wild-type kinase activity in vitro and <60% of normal phosphoprotein levels in vivo. Inactivation of PI3K not only disrupts PIP3-dependent kinase signaling, but surprisingly also attenuates transcripts of numerous IIS components, even upstream of PI3K, and those of signaling molecules that cross-talk with IIS. The age-1(mg44) nonsense mutation results, in F2 adults, in changes to kinase profiles and to expression levels of multiple transcripts that distinguish this mutant from F1 age-1 homozygotes, a weaker age-1 mutant, or wild-type adults. Most but not all of those changes are reversed by a second mutation to daf-16, implicating both DAF-16/ FOXO–dependent and –independent mechanisms. RNAi, silencing genes that are downregulated in long-lived worms, improves oxidative-stress resistance of wild-type adults. It is therefore plausible that attenuation of those genes in age-1(mg44)-F2 adults contributes to their exceptional survival. IIS in nematodes (and presumably in other species) thus involves transcriptional as well as kinase regulation in a positive-feedback circuit, favoring either survival or reproduction. Hyperlongevity of strong age-1(mg44) mutants may result from their inability to reset this molecular switch to the reproductive mode. Author Summary Insulin/IGF-1 signaling (IIS) impacts development, metabolism, and longevity in Caenorhabditis elegans. It has been viewed as a cascade of kinase reactions, chiefly phosphorylation of other kinases, leading to inactivation of the DAF-16/FOXO transcription factor. PI3K, a phosphatidylinositol kinase at the center of this pathway, converts PIP2 to PIP3, instrumental to kinase docking and activation. Here we show that PI3K deficiency elicits transcriptional inhibition of many kinases, including those of IIS itself. This creates a positive-feedback loop, wherein DAF-16/FOXO silences expression of the very kinases that would have inactivated it. In the resulting “flip-flop” genetic switch, either kinase signaling or transcriptional silencing may predominate. We discovered the transcriptional arm of this switch in infertile age-1(mg44) mutants, defective for PI3K activity. The absence of PIP3 and PIP3-dependent kinase activity gives free rein to gene silencing by DAF-16/FOXO. This two-tiered response could scarcely have evolved for the benefit of a sterile mutant; some components presumably serve regulatory functions in normal animals, reinforcing a switch responsive to environmental and internal signals. In age-1(mg44) mutants, complete inactivation of PI3K “fuses” the switch, locking worms into longevity mode. With signaling profoundly silenced, they cannot resume reproduction, but instead acquire a remarkable capacity for individual survival. Introduction IIS depends critically on the presence of PIP3 The IIS pathway, governing developmental arrest, metabolism and life span in Caenorhabditis elegans [1]–[3], is highly conserved from invertebrates to mammals. The single IIS pathway of nematodes corresponds in structure and function to two distinct pathways of mammals that signal metabolic responses to insulin, and growth response to insulin-like growth factor 1 (IGF-1), respectively [4]. IIS disruption was first discovered to enhance longevity in C. elegans [5]–[8], but it was subsequently shown to also extend life in D. melanogaster and mice [9]–[11]. Binding of insulin-like peptides to DAF-2, the insulin/IGF-1 receptor of nematodes, modulates receptor autophosphorylation and activation [12]. Active DAF-2 recruits and phosphorylates the AGE-1 catalytic subunit of phosphatidylinositol 3-kinase (PI3K), which in turn phosphorylates the regulatory subunit. Activated AGE-1 then adds a phosphate to phosphatidylinositol 4,5-diphosphate [PI(4,5)P2] at the inositol-ring 3-position, converting it to phosphatidylinositol 3,4,5-triphosphate [PI(3,4,5)P3 or PIP3]. PIP3 plays a dual role in the canonical insulin/IGF-1 pathway. The first pivotal role is membrane tethering of many signaling molecules including AKT-1 and -2, PDK-1, GSK-3 and protein kinase C [13]–[16]. PIP3-binding recruits or retains many kinases at the cytoplasmic surface of the cell membrane, where these enzymes and their substrates (largely other kinases) are concentrated and, by mass action, interact more efficiently. Because PIP3 quantitatively affects multiple components of the IIS cascade, the influence of its concentration is compounded. In addition, PIP3 binding to AKT-1 allosterically exposes a cryptic site recognized by PDK-1 (phosphatidylinositol-dependent kinase 1), allowing AKT phosphorylation and activation [17]. In this second role, PIP3 may act catalytically, in that a single molecule of PIP3 has the potential to bind successively to many AKT-1 molecules, enabling their activation. Although AKT-1 is the only target for which this allosteric role has been documented [17], it is possible that other signaling molecules that also possess high-affinity PIP3 binding sites (termed “Pleckstrin homology domains”) may be similarly controlled. In any event, we infer that insulinlike signaling should be exquisitely sensitive to PIP3 depletion, and that AKT-1 action (which extends far beyond IIS [18],[19]) may be absolutely dependent on the presence of at least trace amounts of PIP3. The AKT-1/AKT-2/SGK-1 complex, once all of its constituent kinases have been activated by PDK-1 [20], phosphorylates the DAF-16/FOXO transcription factor at sites that block its entry into the nucleus, where it would activate or repress transcription of hundreds of target genes, including many that modulate metabolism, reproduction, life span, and resistance to oxidative stresses [21]–[24]. IIS mutations have wide-ranging effects on longevity Reduction-of-function mutations impairing the C. elegans IIS pathway (e.g., daf-2 and age-1 mutations) cause these worms to arrest development as dauer (alternative stage-3) larvae [1]–[3]. If allowed to mature at a permissive temperature, temperature-sensitive (ts) daf-2 mutant adults can attain twice the normal longevity [6]; life extension ranges from 1.1- to 2.5-fold for different daf-2 alleles [25]. A ts mutant allele of age-1, hx546, was discovered by Klass [26] and reported to confer 40% and 65% life extension at 20° and 25°C respectively [5],[27],[28]. Two constitutive age-1 alleles, m333 and mg44, were initially reported to extend C. elegans life span by 2- to 2.6-fold [2],[8],[29]; these survivals were conducted only for first-generation (“F1”) homozygotes. We recently observed that second-generation age-1(mg44) and (m333) larvae slowly mature at 15–20°C into adults that live close to ten times as long as near-isogenic wild-type controls, and are highly resistant to oxidative and electrophilic stresses [30]. These exceptional worms have mean and maximal adult life spans at least three times those conferred by any other longevity-extending mutation, and throughout their adult lives they appear and behave very much like wild-type worms of a tenth their age. Addition of a second mutation in the daf-16 gene largely or entirely reverses life-span extension and other phenotypes of all daf-2 or age-1 mutations examined to date [3],[6],[29],[30]. Studies of IIS-pathway mutants in C. elegans and other taxa have provided valuable insights into genetic mechanisms regulating life span [4]. The molecular basis for the extreme survival phenotypes of age-1(mg44) F2 homozygotes remains unknown, and cannot be assumed to differ only in degree from molecular mechanisms that underlie 4- to 5-fold lesser life extensions seen in other IIS mutants. The key may be PIP3, which plays both structural and catalytic roles in signal transduction [17],[31], and is thought to mediate both DAF-16-dependent and -independent signaling [32]. Strong age-1 mutants, lacking all class-I PI3K activity, have no direct route to generate PIP3 [31]. As a result, they are expected to be deficient in all enzyme activities that require PIP3, either for activation by regulatory kinases, or for membrane tethering which ensures proximity of kinases to their targets [17],[31]. In the present study, we sought evidence to support such a broad role of PIP3 in the unique properties of age-1(mg44)-F2 adults. This role is an inferred one, since even normal PIP3 levels (in unstressed N2 worms) are too low for detection by existing methods; detectable levels are attained in starved, peroxide-stressed wild-type worms but not in similarly stressed age-1-mutants [33]. We were able to document the expected widespread disruption of protein kinase activity in age-1(mg44)-F2 worms, while making the unexpected observation that the same kinases are chiefly inhibited at the transcriptional level. Direct measurement of transcripts confirms silencing of kinase gene expression, leading us to propose a novel “hybrid” positive-feedback loop in which the IIS kinase cascade that inhibits the DAF-16/FOXO transcription factor, is itself attenuated by DAF-16-mediated transcriptional silencing of upstream kinases. Results Very long-lived age-1 mutant worms are broadly deficient in protein kinase activity The age-1(mg44) kinase-null mutants should be deficient in phosphatidylinositol 3,4,5-triphosphate production. Given the importance of the PIP3 molecule in signal transduction events originating from many membrane-receptor kinases, we anticipated that phosphorylation of numerous proteins may be impaired in those mutants. To initially assess the breadth of this impairment, we compared in vitro kinase activities with respect to endogenous substrates for five age-1 mutant strains, each normalized to a wild-type N2DRM stock (Figure 1A–1C
Panels A and B illustrate a typical experiment, and panel C summarizes results for replicate experiments with independent expansions of each group. The first-discovered and most widely used age-1 allele, hx546 [5],[27],[28], showed 32% less kinase activity than N2DRM (Figure 1C = 0.05), although the difference was consistently much greater for specific bands (see Figure 1BThe consequences of adding a daf-16 mutation are quite different for the two age-1 alleles: in age-1(hx546) worms, the daf-16(m26) mutation more than doubled the in vitro kinase activity, from 68% of wild-type to 160%, whereas this mutation restored less than half of the kinase deficiency due to the age-1(mg44) allele. Insofar as kinase suppression is reversed in daf-16; age-1(mg44) double mutants, we infer that activity is inhibited in part through the DAF-16/ FOXO transcription factor. However, reversion is far from complete, by either the m26 (point-mutant) or the mu86 (large-deletion) allele of daf-16 (see Figure 1C To corroborate low protein-kinase activity of age-1(mg44) adults, and to distinguish whether they are deficient for many protein kinases or a few very active ones, we constructed arrays of 70 synthetic peptides comprising 50 near-consensus kinase sites from the C. elegans proteome and 20 from mouse or human proteins. Phosphorylation in vitro was observed on 29 peptides, representing potential substrates for at least 18 distinct kinases (Figure S2 and Table S1). Protein kinase activity in extracts from age-1(mg44) F2 adults was reduced by 1.8- to >8-fold, relative to isogenic N2DRM postgravid worms (each at nominal P<0.05), for 22 of the 29 kinase targets that were phosphorylated in vitro. Addition of the daf-16(mu86) mutation produced essentially complete reversion, or hyper-reversion (activity>N2DRM), for 17 of those 22 peptides. In view of the reduced protein-kinase activity of age-1(mg44) worms, we anticipated that their steady-state level of protein phosphorylation would also be depressed. To assess this, phosphoproteins were separated by acrylamide gel electrophoresis and compared among wild-type and age-1-mutant strains of C. elegans (Figure 1D–1F
Transcriptional suppression of signal-transduction genes in age-1(mg44) worms F2 homozygotes for age-1(mg44) are expected to produce only truncated class-I PI3KCS, lacking the kinase domain and C-terminus of the protein. These worms indeed lack the main bands recognized by antibodies to the AGE-1 C-terminal region (Figure S3); residual bands may represent class-II and -III homologs of AGE-1. PIP3, formed exclusively by class-I PI3K, should thus be greatly reduced or absent. PIP3 is strictly required for PDK-1 activation of AKT kinase, which then phosphorylates and inactivates DAF-16/FOXO. Kinases that require PIP3 binding for membrane tethering or kinase activation [17],[31], such as AKT, PDK-1, and SGK-1, are expected to show marked suppression of activity, which cannot be directly reverted by a daf-16 mutation. The surprising observation that mutations to daf-16 restore nearly half of the age-1 (mg44)-F2 kinase deficiency, and >70% of its phosphoprotein deficit, implies that their inhibition must be mediated in part by DAF-16/FOXO. Such regulation could be direct (DAF-16 suppresses transcription of many kinase genes) or indirect (DAF-16 suppresses one or a few kinases, or stimulates one or a few phosphatases, which then suppress other kinases by impeding or opposing their phosphorylation). To test direct effects of DAF-16/FOXO, we used real-time polymerase chain reaction (RT-PCR) to quantify the effects of age-1 alleles, with or without added inactivation of daf-16, on transcript levels for IIS genes and a panel of other signaling components, representing a wide range of transduction pathways. IIS genes We first assessed genes involved in insulin-like signaling. Results of a comparison of independent biological replicates for each strain are shown graphically in Figure 3
The C. elegans genome contains at least 38 genes encoding putative insulinlike peptides (ILPs), although functional roles in the initiation of IIS have been established for rather few ILPs [12]. Genes encoding six ILPs, known or presumed ligands of the DAF-2 insulin/IGF-1 receptor, were selected for study based on prior evidence of a biological function, as cited in WormBase (www.wormbase.org). Five of these (including genes for known IIS antagonists INS-1 and INS-18) were upregulated 3- to 10-fold in age-1(mg44) F2 adults, whereas the ins-7 ILP gene—an established ILP-receptor agonist for which RNA interference (RNAi) extends life [39]—had roughly half the wild-type transcript level. In addition, two positive targets known to be induced by DAF-16/FOXO [24],[40] serve to confirm its enhanced activity in age-1(mg44) adults: sod-3, encoding mitochondrial superoxide dismutase-3 (up 8×), and R11A5.4, which encodes phosphoenolpyruvate carboxykinase (PEPCK), a key activator of gluconeogenesis (up 8.5×). For the most part, this profile of IIS transcripts is consistent with concerted silencing of the IIS pathway in age-1(mg44), leaving DAF-16 in its active state, unphosphorylated at sites that would exclude it from the nucleus. Thus, in age-1(mg44) F2 adults, insulinlike peptide genes that antagonize IIS are upregulated while ins-7 (the only confirmed IIS agonist) is downregulated. Genes supplying the IIS kinase cascade that inactivates DAF-16/FOXO (daf-2, age-1, sgk-1, and pdk-1) are all downregulated, whereas ist-1, encoding a homolog of mammalian IRS-1 and IRS-2 [41] which serve as convergence points for many inhibitory inputs from other signaling pathways [41],[42], is upregulated. Moreover, aak-2, the sole AMP-dependent kinase (AMPK) gene implicated in DAF-16/FOXO activation [43],[44], and shown to extend lifespan when over-expressed [45], is upregulated in age-1(mg44) F2 adults (Table 1). Apparent exceptions include the low transcript levels for two genes that antagonize IIS: daf-18, encoding the PIP3 3-phosphatase PTEN, and par-5, encoding one of several 14-3-3 proteins that sequester IIS-phosphorylated DAF-16—genes that arguably are superfluous in the absence of PIP3 and IIS-mediated phosphorylation of DAF-16, respectively. Other signal transduction genes In view of the global suppression of kinase activities (Figure 1 Altogether, this targeted gene survey indicates widespread silencing of signal-transduction genes in age-1(mg44) F2 adults, with significant declines relative to N2DRM (P<0.01) for 23 of the 47 genes tested, and increases for 12 genes. The declines imply attenuation of IIS, TGF-β, and ERK/MAPK pathways, and either silencing or redirection of the AMPK/TOR nutrient-sensing pathway. Two pathways implicated in immune and stress responses, p38/MAPK and JNK/MAPK, do not appear to have all outputs inhibited at the transcript level. The bias toward inhibition over induction cannot be a reflection of global transcriptional silencing, because all data were normalized to the mean of three control genes (β-actin, T08G5.3, and Y71D11.3) that did not change among the strains tested. However, the bias is consistent with the results of a microarray survey (Ayyadevara et al., submitted) which indicated that differential gene expression in strong age-1 mutants reflects primarily transcriptional suppression targeting a few hundred genes, largely or entirely specific to those alleles. Expression changes in age-1(mg44) F2 adults do not simply recapitulate a younger adult state in wild-type worms Might the observed differences in gene expression reflect the considerable differences in physiological age (or in chronological age) among the young-adult worms being compared? Gene expression in Drosophila lines, varying in longevity by up to threefold, was reported to fall into two classes: some genes alter transcript levels over time, independent of lifespan, while others show expression patterns that scale with lifespan [49]. Of the genes that appeared strongly modulated in age-1(mg44) F2 adults, a subset was chosen to represent four signaling pathways, and assessed in wild-type N2DRM adults at several adult ages, as well as one or two ages of age-1(mg44) F2 adults. This time series (Figure 4
Silencing involves both daf-16–dependent and –independent routes Of 35 nominally significant (P<0.01) transcriptional differences between age-1(mg44) F2 and N2DRM adults, 25 were completely reversed (to within 20% of the N2DRM level, or over-reverted) by mutations inactivating daf-16; a further 9 genes showed partial reversion, while two, daf-2 and pmk-2, did not revert at all. Four instances of partial or negligible reversion (ins-14, daf-2, pmk-2 and pmk-3) entail expression levels for daf-16(mu86); age-1(mg44) adults that differed significantly from N2DRM (each P<0.01; combined P<10−9). Results were similar for the m26 and mu86 alleles of daf-16; Table 1 shows only data for the mu86 allele in which most daf-16 exons are deleted. These data demonstrate that age-1(mg44) F2 effects on transcription are primarily mediated by DAF-16/FOXO, but are also supplemented by DAF-16-independent mechanisms—paralleling the conclusions drawn from earlier data on daf-2 mutants [50]. Expression changes differ between F2 and F1 age-1(mg44) homozygotes Transcriptional modulation is also seen in first-generation (F1) age-1(mg44) adults, for which inductions occasionally exceeded the level seen at F2. In fact, the three highest induction factors were observed in F1 adults, for ins-5 (24×), ins-14 (27×), and atf-2 (44×), with ins-6 (11×) also showing substantially higher transcript levels in F1 worms than in F2. However, expression of 21 genes is altered 2- to 8-fold more in F2 worms than in F1 (e.g., ist-1, vps-34, daf-18, sod-3, smk-1, sir2.1, aak-1 and daf-15), while 6 genes were roughly equal at the two generations (age-1, sgk-1, daf-3, let-60, mek-1, and gsk-3). Clearly, the consequences of maternal protection differ among these genes. Comparison to other IIS mutants and to dauer larvae F2 age-1(mg44) adults generally show far more pronounced transcriptional effects than the weaker age-1 allele, hx546 (Figure 3 F2 age-1(mg44) adults differed significantly from dauer larvae for 43% (20/46) of the signal-transduction genes tested for both; the same number (20) had transcript levels that were within twofold of those in dauer larvae (Table 1)—suggesting that these two very long-lived populations achieve resistance to aging through distinct but partially overlapping gene-expression strategies. The transcript-level changes observed in age-1(mg44) F2 adults were cross-checked against those previously reported for either daf-2(e1370) adults, wild-type dauer larvae, or both [21], [24], [51]–[53]. Few commonalities were found between the present data and these gene lists, which comprise the most highly and significantly altered genes in microarray surveys. The differences may in part reflect the greater sensitivity of RT-PCR to detect and quantify low-abundance transcripts; however, data in Tables 1 and Table S2 imply that transcriptional shifts for age-1(mg44) F2 adults differ both qualitatively and quantitatively from those seen in other mutants. Functional consequences of transcriptional suppression in age-1(mg44) worms F2 age-1(mg44) adults, which are 4- to 5-fold longer-lived than F1 adults (comparing data of [8],[29] to [30]), also outperform their parents with respect to resistance to oxidative and electrophilic stresses (Figure 5A and 5B
Most or all of the age-1(mg44)-downregulated genes are essential for nematode growth and development. That is, double-stranded RNAs (dsRNAs) targeting them, administered to developing C. elegans, produce embryonic lethality or larval arrest [54]–[56]. The impact of such knockdown, however, has thus far remained largely untested in adults. Because resistance to oxidative stresses is a common feature of many long-lived C. elegans mutants [57], and in particular parallels longevity in the age-1 allele set studied here (Figure 5 Hydrogen peroxide resistance was measured in duplicate experiments, for wild-type N2DRM worms that had been exposed to dsRNA-expressing bacteria targeting 10 genes for which transcript levels are markedly reduced in age-1(mg44)-F2 adults. Genes were selected from among those not directly involved in the IIS pathway, but representing a variety of other signaling pathways, and for which RNAi constructs were available from the Ahringer library [56]. E. coli, either harboring an empty-vector control or expressing one of 10 gene-targeted dsRNA species, were fed to mature adults (days 3 through 6 after the L4/adult molt) so as to preclude effects on development. Survival curves, during subsequent exposure to 5-mM H2O2, are shown in Figure 5C Genes (and encoded proteins) for which RNAi knock-down conferred a protective effect were daf-3 (SMAD transcription factor) and daf-4 (TGF-β receptor, a Ser/Thr kinase), both involved in TGF-β signaling; aak-1 (AMP-dependent protein kinase 1), part of the AMPK/TOR pathway; let-60 (RAS-family GTPase activating MAPK), part of the ERK-MAPK pathway, and vps-34 (class-III PI3KCS), involved in vesicular trafficking and autophagy. None of these individual RNAi effects matched the peroxide survival of untreated age-1(mg44) F2 adults at 62 days of adult age (large diamond symbols, Figure 5C Discussion First-generation homozygotes for the age-1(mg44) mutation develop normally into fertile adults at 15–25°C, and display stress resistance and life extension typical of many IIS mutants [8],[14],[29]. In contrast, their progeny—second generation homozygotes—develop slowly at 15–20°C, to form infertile adults that are far more stress resistant and at least four-fold longer lived than other IIS mutants [30]. Maternal protection (oocyte carryover of age-1 mRNA, AGE-1 kinase or its PIP3 product, synthesized by the heterozygous parent) is thought to blunt both the stress-resistance and longevity traits to approximately those of a weaker age-1 or daf-2 allele [30]. We here show that total kinase activity is also attenuated more severely in age-1(mg44) adults at the F2 than the F1 generation (see Figure 1C Consequences of altered gene expression for IIS and other pathways Transcriptional effects within the IIS pathway seem fully consistent with impaired insulinlike signaling, which might be expected to further augment survival through the same mechanisms employed by weaker IIS mutations. Moreover, repression of class-II and class-III PI3K catalytic-subunit genes (Table 1) would impede formation of PI(3)P and PI(3,4)P2, suppressing alternative routes to PI(3,4,5)P3. Increased expression of aak-2 contributes to activation of DAF-16/FOXO, further opposing IIS (which inhibits this transcription factor) and increasing life span [43],[44]. In addition to effects on IIS genes, however, age-1(mg44)-F2 adults also show striking transcriptional attenuation of several other signal transduction pathways that interact with IIS and with one another. TGF-β endocrine/paracrine signaling is active in development, and modulates several other signaling pathways including p38/MAPK and ERK/MAPK [46]. Both daf-1 and daf-4, encoding type-I and -II TGF-β receptors, respectively, are downregulated 4- to 5-fold in age-1(mg44)-F2 adults. Expression is also reduced 3-fold for daf-3, encoding a co-SMAD transcription factor deployed by several pathways including TGF-β. Perhaps in partial compensation for this signaling downregulation, the daf-7 gene encoding a TGF-β-family ligand/agonist is 5-fold upregulated. Silencing of TGF-β signaling, by RNAi directed at daf-3 or daf-4, improves survival in the presence of hydrogen peroxide, consistent with a prior observation that daf-1, -4 and -7 mutants are long-lived [46]. AMPK/TOR signaling has been implicated in innate immunity and stress responses. Although it remains controversial whether the primary response is to the microbe or to the stress it causes [47], both could be secondary to its role in nutrient sensing [37],[43]. AAK-1 and AAK-2 are regulated by the PAR-4 transcription factor [37],[58],[59], and aak-1 knockdown by RNAi confers resistance to oxidative stress (Figure 5C ERK/MAPK signal-transduction is essential for many developmental processes; because the constituent genes are also expressed in adult nematode tissues, they are presumed to have post-developmental functions not yet defined [62]–[64]. All six genes tested in this pathway are markedly downregulated, by 3- to >6-fold (Table 1), and RNAi inhibition of let-60 (encoding a RAS membrane co-receptor that initiates ERK/MAPK signaling) significantly improves survival of oxidative stress (Figure 5C Rationale, anomalies, and resolutions The most dramatic effects of gene mutations on life span have involved hypomorphic (loss-of-function) mutations, and the genes affected have been termed aging “master genes”. The genes encoding IIS components provide the best-studied example. IIS, in common with many “master genes” and essentially all signaling pathways, regulates numerous other genes. In the case of IIS, a number of these are modulated in ways that are protective, or otherwise conducive to long life, such as upregulation of GSTs and other detoxification genes, which are among the “foot soldiers” of longevity assurance [65],[66]. However, we should not expect all such downstream consequences to confer uniformly pro-longevity effects; each gene is likely to serve several “masters”, and its level of expression will depend on the genetic, environmental, and signaling context. In keeping with this perspective, the downstream manifestations of longevity assurance genes are far less conserved, both in evolution and between distinct physiological states of a given species, than are the over-arching pathways and the functions they serve [67]. Improved stress resistance and survival of age-1(mg44) F2 worms, apparently arising from transcriptional attenuation of signaling pathways presumed to be protective, poses an intriguing paradox. These pathways, activated by nutrient deficiency, pathogens, or growth factors, have been reported to cross-talk with IIS at diverse levels [19], [43]–[47],[68],[69]. This suggests a complex fabric of signaling interactions, for which the impact of silencing multiple components cannot be predicted. Moreover, signaling that promotes survival in a variable or hostile setting may entail energy costs and harmful side-effects that would be unwarranted in a constant, pathogen-free environment with abundant food. An organism that avoids the deleterious aspects of these surveillance systems may thus reap survival benefits under benign conditions. In several instances, the expression changes seen in strong-age-1 mutants appear to oppose their longevity or stress-resistance, based on the effects of down- or upregulation previously reported for the same genes. For example, age-1(mg44) F2 adults downregulate daf-18, which encodes the PIP3 3-phosphatase, PTEN. This would be expected to elevate the steady-state level of PIP3, thereby enhancing IIS and reducing longevity of normal worms. However, in the absence of AGE-1/PI3KCS kinase activity, there may be little or no PIP3 substrate on which PTEN could act. A second example is downregulation in age-1(mg44) F2 adults of skn-1, encoding a transcription factor responsive to oxidative damage and regulated via IIS [70]–[72]. Reduced expression of skn-1 seems at odds with increased oxidative-stress resistance and longevity; however, these very long-lived worms may generate lower levels of reactive oxygen species, thereby reducing skn-1 induction. RNAi to vps-34 (encoding a class-III PI3KCS required for vesicular trafficking and autophagy [73]) was recently shown to block life extension of eat-2(ad1116) and daf-2(mu150) mutants, although not of wild-type worms [58]. Autophagy is induced by TOR deficiency [58], and several TOR signaling components are downregulated in F2 worms (Table 1). Considering this, autophagy should be at least moderately induced in those worms, and its absence would not account for low expression of vps-34. These results argue against any direct role of vps-34 attenuation in the exceptional longevity of age-1(mg44) F2 worms. The possibility remains, however, that vps-34 downregulation could reinforce PIP3-depleting effects of a strong age-1 mutation. Downregulation in age-1(mg44) worms, of transcripts for let-60/RAS and five other members of the ERK-MAPK cascade, might be expected to oppose additional life extension beyond that typical of IIS mutants, because a let-60 gain-of-function mutation enhances daf-2 life extension [74]. RNAi targeting smk-1, encoding a transcriptional coactivator shared by DAF-16 and PHA-4 [75], reduces stress-resistance and lifespan of daf-2(e1370) worms [76], whereas the effect on wild-type worms is controversial [34],[76]. Although smk-1 knockdown impairs sod-3 expression in daf-2 worms [34], we found 9-fold elevation of sod-3 transcripts in the face of a 72% drop in smk-1 expression in age-1(mg44) (Table 1). Finally, sir-2.1 overexpression was reported to extend lifespan, and knock-down to shorten it [77],[78], whereas we found almost 4-fold downregulation of sir-2.1 in age-1(mg44)-F2 adults. Although contradictory in the context of extreme stress resistance and longevity, all six of these “exceptions” are also mirrored, in most cases to a lesser degree, in dauer larvae (Table 1), a robust state of developmental arrest that can endure for months without reducing adult life span [1],[79],[80]. This raises the possibility that for these genes, the effects of downregulation are context-dependent, and may be beneficial in worms that are already highly protected from stress and aging. Alternatively, these expression changes may follow from regulatory mechanisms shared by age-1(mg44) adults and N2 dauers, and yet work in opposition to their robustness. This is plausible in the case of a severe loss-of-function mutant, effects of which are not orchestrated, but is difficult to reconcile with a highly-evolved alternative developmental state such as the dauer larva. Perhaps, rather than a single coherent program, the patterns we observe reflect aberrant triggering in the adult of one or more regulatory mechanisms that are normally utilized in developmental or metabolic regulation. This particular combination of mechanisms could be the serendipitous result of a profound alteration in PIP3 levels which in turn impacts multiple pathways. PI3Kcs-mutant effects are largely, but not entirely, mediated by DAF-16/FOXO The expression profile of age-1(mg44) worms depends largely on DAF-16/FOXO, consistent with prior evidence that C. elegans IIS operates mainly through this transcription factor, impacting several hundred target genes [2],[21],[22],[29],[52],[81]. Although DAF-16/FOXO has been regarded largely as a transcriptional activator [21],[82], it also effects negative regulation of many genes [24]. In our selected panel of genes, two-thirds (22/33) of the DAF-16-mediated effects of age-1(mg44) mutation involve reduced transcript levels, indicating that silencing prevails for gene transcripts that encode kinases and other mediators of intracellular signaling. Twenty-eight genes (of the 33 for which transcripts appear to be primarily regulated via DAF-16/FOXO) were mapped for DAF-16 binding sites within 5 kb upstream of the initiation codon (Table 1). Of these, 21 (75%) have exact matches to one or both of the two known consensus sites, GTAAA(C/A)AA and CTTATCA. Genes lacking such sites may be indirect targets of DAF-16/FOXO, but considering that those motifs occur at almost the same frequency in the genome at large [81], as in DNA immunoprecipitated with antibody to DAF-16/FOXO [52], it is possible that precise motif matches are neither necessary nor sufficient for DAF-16 binding. In other words, near-match sequences might be able to bind DAF-16, while even perfect-match motifs may require additional features in nearby DNA. Implication of a hybrid feedback loop with kinase and transcriptional components It is surprising that hyperactivation of DAF-16/FOXO in age-1(mg44) F2 adults silences essentially the entire IIS pathway. This implies a positive feedback loop, in which DAF-16/FOXO imposes transcriptional silencing on the very kinases that would inhibit its own nuclear localization and hence access to target genes (Figure 6
When IIS kinase signaling predominates (the reproductive state), it suppresses DAF-16/FOXO activity. Activation of PI3K favors PIP3 production and AKT activation, both of which promote cell proliferation [18],[31],[85]. However, IIS can switch to a second, functionally distinct, state: when kinase signaling is weak, DAF-16/FOXO becomes activated. As we have demonstrated, active DAF-16/FOXO transcriptionally silences its own upstream regulatory kinases, which otherwise would have impeded DAF-16/FOXO action by preventing its nuclear localization. Therefore, the low-signaling, longevity state of IIS is self-sustaining. Biologically, this state promotes dauer formation during development, or life-extension and delayed reproduction in the adult (reviewed in [4]). Signals that inhibit IIS kinases or augment DAF-16/FOXO action, if sufficient, trigger a switch from reproductive to longevity state in which DAF-16/FOXO promotes somatic protective mechanisms (Figure 6 The concept of a “genetic switch” for dauer formation is not new [1],[86],[87], and has even been demonstrated to constitute a bistable feedback loop [21],[87]. Nevertheless, a dual-level (kinase/transcriptional) feedback mechanism had not previously been proposed or described. Any such “flip-flop” circuitry allows the organism a simple binary choice in response to its environment: early reproduction under benign conditions, or postponed reproduction and extended survival in harsher conditions. Mutational disruption of IIS forces dauer formation, irrespective of environment, although larvae with temperature-sensitive mutations can mature at lower temperatures into long-lived adults. Recovery from the dauer state requires that pro-reproductive-state kinases retain partial function, so that favorable signals (restoration of food, absence of stress and crowding) can reset the switch to the reproductive mode; this requirement is demonstrated by the impaired post-dauer recovery of IIS-defective mutants [86]. Nonsense mutations truncating AGE-1 produce an extreme phenotype that forfeits this option, while acquiring a distinctive transcriptional profile and greatly enhanced survival. Details of the mechanism or mechanisms, by which elimination of PI3K activity blocks exit from the longevity mode and promotes extreme longevity, remain to be elaborated. Features described in this report, which may contribute, include transcriptional silencing of upstream and collateral signaling components, and accompanying loss of multiple kinase activities. Infertile mutants may thus reveal new strategies to extend life well beyond the limits imposed by natural selection, which of course requires reproduction. In view of the striking evolutionary conservation of the IIS pathway, and the emerging parallels between inter-pathway cross-talk in nematodes and mammals [16],[19],[47],[68],[69], the mechanistic insights afforded by very long-lived worms are likely to also apply to insulin and IGF-1 pathways of mammals. Materials and Methods Strains Stress resistance Assays of survival in the presence of 5-mM hydrogen peroxide or 10-mM 4-hydroxynonenal were modified from Ayyadevara et al. [91]. Wild-type (N2DRM) worms were assayed at day 3–4 of adulthood (~6 d post-hatch). For RNAi experiments, day-1 adults were washed in S-buffer [92] and transferred to nutrient-agar plates seeded with dsRNA-expressing E. coli [56]. After 3 days at 20°C, 20 worms from each RNAi treatment were transferred to 24-well plates containing 300 µl of S Buffer plus 5 µg/ml cholesterol, supplemented, as indicated, either with 5-mM H2O2 (freshly diluted from 30% H2O2, Sigma) or with 10-mM 4-HNE (freshly obtained by acid hydrolysis of 4-HNE dimethylacetal which was synthesized according to [93]. Survival was scored as described [30],[89]. In vitro phosphorylation assay Worms grown at 20°C were quickly frozen in liquid nitrogen to preserve endogenous kinase activity. Worms suspended in 50-mM Tris pH 7.5, 80-mM β-mercaptoethanol, 2-mM EDTA, 1-mM PMSF, and Protease Inhibitor Cocktail I (CalBiochem), were ground at −78°C and sonicated (VIRTIS Virsonic 475, setting 2.5, 0°C) in six 10-s bursts interspersed with 2-min cooling periods. Kinase activity toward endogenous substrates was assessed in cleared supernatants after centrifugation (10 min, 11,000 g), representing 20 µg protein in 100 µl of buffer containing 50-mM Tris pH 7.5, 12.5-mM MgCl2 and (for endogenous substrates) 8–10 µCi γ-32P-ATP (NEN). After 1 min at 30°C, quenched samples were electrophoresed on 10% SDS-polyacrylamide gels (Invitrogen), which were stained with SYPRO Ruby (Invitrogen), and dried under vacuum. 32P β-emissions of bands migrating slower than a 25-kDa protein marker (Invitrogen), were imaged and quantified per lane after 6-h phosphor-screen exposure (Storm, Molecular Dynamics). Peptide arrays were incubated as above, 60 min at 30°C, but with addition of phosphatase inhibitors and 1-mM cold ATP rather than 32P-ATP. Arrays were then stained with Pro-Q Diamond (Invitrogen), and phosphorylation was quantified by fluorescence imaging (excitation/emission at 550/580 nm) with a ScanArray 5000 (GSI Lumonics). In vivo phosphoprotein detection and quantitation Total protein (20 µg), extracted from each strain as above, was loaded onto NuPAGE 4–12% gradient gels (Invitrogen) and electrophoresed 1 hour at 200 V. Phosphoproteins were quantified by Pro-Q Diamond (Invitrogen) fluorescence, which depends linearly on protein concentration (>1000-fold range). Protein load was assessed by Coomassie Blue (BioRad) staining. Phosphorylated (23.6, 45.0 kDa) and unphosphorylated (14.4, 18.0, 62.6, 116.2 kDa) protein standards (BioRad) furnished positive and negative controls. Transcript quantitation by RT–PCR Expression of selected genes was assessed by real-time polymerase chain reaction after an initial round of reverse transcription. Total RNA was purified from each strain (RNeasy, Qiagen), and cDNAs reverse-transcribed (SuperScript III, Invitrogen), followed by RT-PCR (Opticon2, MJ Research, using SYBR Green, Roche). Figure S1 In vitro kinase activity for endogenous substrates is reduced in age-1(mg44) homozygotes, but not in dauer larvae. Kinase activity was assessed for N2DRM day-6 adults and eggs they produce, eggs laid by age-1(mg44) F1 adults, F1 adults at days 2.5 and 6.5 of adulthood, age-1(mg44) F2 day-1 adults, daf-16(mu86); age-1(mg44) adults, and N2DRM dauer larvae. Kinase activity of sonicated lysates was assessed as described in the legend to Figure 1 (1.42 MB TIF) Click here for additional data file.(1.3M, tif) Figure S2 Phosphorylation in vitro of peptide arrays. Fluorescence images are displayed of peptide arrays (JPT Peptide Technologies GmbH, Berlin) shown printed in duplicate blocks, stained with Pro-Q Diamond (Invitrogen) after 1-h incubation with worm homogenates containing phosphatase and protease inhibitors and 1-mM ATP. Equal protein concentrations from each strain (N2DRM, age-1(mg44), and daf-16(mu86); age-1(mg44)) were incubated on slides, 60 min at 30°C. Note that “reversion” by daf-16(mu86) enhances some kinases not evident even in the wild-type (N2DRM) sample. (0.77 MB TIF) Click here for additional data file.(752K, tif) Figure S3 Adult age-1(mg44) F2 homozygotes are deficient in PI3Kcs protein. Western blots are shown, after denaturing (A) or native (B) polyacrylamide gel electrophoresis. Electrochemiluminescence (GE-Amersham “ECL-plus”) detected secondary antibody (goat anti-rabbit IgG coupled to horseradish peroxidase) to rabbit monoclonal antibodies binding the C-terminal region of C. elegans phosphatidylinositol 3-kinase p110 catalytic subunit, or to cytoplasmic β-actin as a loading control (Santa Cruz Biotech., Santa Cruz CA). Each lane contains 10 µg of total protein. (0.25 MB TIF) Click here for additional data file.(245K, tif) Table S1 Peptide phosphorylation by C. elegans kinases in vitro. Mean±SD is given for ProQ Diamond fluorescence (in arbitrary units) of synthetic peptides spotted in 2–4 arrays, after subtraction of mean background measured on negative-control spots. The kinases that phosphorylate these peptides are not known; those listed in column 2 may phosphorylate the residues underlined, based on consensus sites for the corresponding mammalian kinase. (0.08 MB DOC) Click here for additional data file.(76K, doc) Table S2 Gene expression data, quantified by real-time polymerase chain reaction, comparing three age-1 mutant groups to daf-2(e1370) mutants. Worms in the age-1(mg44) F2 group are sterile adults; others are post-gravid adults. Significance of difference from N2DRM (t-test): °, nominally significant at P<0.05; *, P<0.01; **, P<0.001; ***, P<1E−4; ****, P<1E−5, *****, P<1E−6. (0.05 MB DOC) Click here for additional data file.(52K, doc) Acknowledgments We thank Ramani Alla and Rajani Ayyadevara for expert technical assistance, Eric Siegel for statistical consultation, and Drs. Piotr Zimniak and Joan McEwen for helpful suggestions. Footnotes Three of the authors (CT, AS and RJSR) are listed as the inventors in a patent filed by the University of Arkansas for Medical Sciences, relating to novel aspects of second-generation homozygotes for the age-1(mg44) and (m333) mutant alleles, underlying their extreme longevity and stress resistance. This work was supported by grant P01-AG20641 to RJSR from the U.S. National Institutes of Health (National Institute on Aging) and by a Research Career Scientist Award (to RJSR) from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. References 1. Riddle DL, Swanson MM, Albert PS. Interacting genes in nematode dauer larva formation. Nature. 1981;290:668–671. [PubMed] 2. Larsen PL, Albert PS, Riddle DL. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics. 1995;139:1567–1583. [PubMed] 3. Dorman JB, Albinder B, Shroyer T, Kenyon C. The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics. 1995;141:1399–1406. [PubMed] 4. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell. 2005;120:449–460. [PubMed] 5. Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988;118:75–86. [PubMed] 6. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993;366:461–464. [PubMed] 7. Lin K, Dorman JB, Rodan A, Kenyon C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science. 1997;278:1319–1322. [PubMed] 8. Tissenbaum HA, Ruvkun G. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics. 1998;148:703–717. [PubMed] 9. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, et al. Extension of Life-Span by Loss of CHICO, a Drosophila Insulin Receptor Substrate Protein. Science. 2001;292:104–106. [PubMed] 10. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, et al. A Mutant Drosophila Insulin Receptor Homolog That Extends Life-Span and Impairs Neuroendocrine Function. Science. 2001;292:107–110. [PubMed] 11. Bartke AJ, Wright JC, Mattison JA, Ingram DK, Miller RA, et al. Extending the lifespan of long-lived mice. Nature. 2001;414:412. [PubMed] 12. Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, et al. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev. 2001;15:672–686. [PubMed] 13. Paradis S, Ailion M, Toker A, Thomas JH, Ruvkun G. A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev. 1999;13:1438–1452. [PubMed] 14. Paradis S, Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 1998;12:2488–2498. [PubMed] 15. Hemmings BA. PtdIns(3,4,5)P3 gets its message across. Science. 1997;277:534. [PubMed] 16. Singh SS, Chauhan A, Brockerhoff H, Chauhan VP. Activation of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. Biochem Biophys Res Commun. 1993;195:104–112. [PubMed] 17. Stokoe D, Stephens LR, Copeland T, Gaffney PRJ, Reese CB, et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of Protein Kinase B. Science. 1997;277:567–570. [PubMed] 18. Shtilbans V, Wu M, Burstein DE. Current overview of the role of Akt in cancer studies via applied immunohistochemistry. Ann Diagn Pathol. 2008;12:153–160. [PubMed] 19. Gami MS, Iser WB, Hanselman KB, Wolkow CA. Activated AKT/PKB signaling in C. elegans uncouples temporally distinct outputs of DAF-2/insulin-like signaling. BMC Dev Biol. 2006;6:45. [PubMed] 20. Hertweck M, Gobel C, Baumeister R. C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev Cell. 2004;6:577–588. [PubMed] 21. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424:277–283. [PubMed] 22. McElwee J, Bubb K, Thomas JH. Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell. 2003;2:111–121. [PubMed] 23. Lee SS, Kennedy S, Tolonen AC, Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science. 2003;300:644–647. [PubMed] 24. Murphy CT. The search for DAF-16/FOXO transcriptional targets: approaches and discoveries. Exp Gerontol. 2006;41:910–921. [PubMed] 25. Gems D, Sutton AJ, Sundermeyer M, Albert PS, King K, et al. Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics. 1998;150:129–155. [PubMed] 26. Klass MR. A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results. Mech Ageing Dev. 1983;22:279–286. [PubMed] 27. Friedman DB, Johnson TE. Three mutants that extend both mean and maximum life span of the nematode, Caenorhabditis elegans, define the age-1 gene. J Gerontol. 1988;43:B102–B109. [PubMed] 28. Johnson TE. Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging. Science. 1990;249:908–912. [PubMed] 29. Morris JZ, Tissenbaum HA, Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature. 1996;382:536–539. [PubMed] 30. Ayyadevara S, Alla R, Thaden JJ, Shmookler Reis RJ. Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell. 2008;7:13–22. [PubMed] 31. Hawkins PT, Anderson KE, Davidson K, Stephens LR. Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans. 2006;34:647–662. [PubMed] 32. Vellai T, McCulloch D, Gems D, Kovacs AL. Effects of sex and insulin/insulin-like growth factor-1 signaling on performance in an associative learning paradigm in Caenorhabditis elegans. Genetics. 2006;174:309–316. [PubMed] 33. Weinkove D, Halstead JR, Gems D, Divecha N. Long-term starvation and ageing induce AGE-1/PI 3-kinase-dependent translocation of DAF-16/FOXO to the cytoplasm. BMC Biol. 2006;4:1. [PubMed] 34. Wolff S, Ma H, Burch D, Maciel GA, Hunter T, et al. SMK-1, an essential regulator of DAF-16-mediated longevity. Cell. 2006;124:1039–1053. [PubMed] 35. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:154–155. [PubMed] 36. Wang Y, Oh SW, Deplancke B, Luo J, Walhout AJ, et al. C. elegans 14-3-3 proteins regulate life span and interact with SIR-2.1 and DAF-16/FOXO. Mech Ageing Dev. 2006;127:741–747. [PubMed] 37. Narbonne P, Roy R. Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling. Development. 2008;123:611–619. 38. Mihaylova VT, Borland CZ, Manjarrez L, Stern MJ, Sun H. The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc Natl Acad Sci U S A. 1999;96:7427–7432. [PubMed] 39. Kawano T, Ito Y, Ishiguro M, Takuwa K, Nakajima T, et al. Molecular cloning and characterization of a new insulin/IGF-like peptide of the nematode Caenorhabditis elegans. Biochem Biophys Res Commun. 2000;273:431–436. [PubMed] 40. Chakravarty K, Cassuto H, Reshef L, Hanson RW. Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol. 2005;40:129–154. [PubMed] 41. Wolkow CA, Munoz MJ, Riddle DL, Ruvkun G. Insulin receptor substrate and p55 orthologous adaptor proteins function in the Caenorhabditis elegans daf-2/insulin-like signaling pathway. J Biol Chem. 2002;277:49591–49597. [PubMed] 42. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, et al. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol. 2007;27:3569–3577. [PubMed] 43. Greer EL, Dowlatshahi D, Banko MR, Villen J, Hoang K, et al. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol. 2007;17:1646–1656. [PubMed] 44. Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 2004;18:3004–3009. [PubMed] 45. Curtis R, O'Connor G, DiStefano PS. Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell. 2006;5:119–126. [PubMed] 46. Shaw WM, Luo S, Landis J, Ashraf J, Murphy CT. The C. elegans TGF-beta Dauer pathway regulates longevity via insulin signaling. Curr Biol. 2007;17:1635–1645. [PubMed] 47. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, et al. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2006;2:e183. doi:10.1371/journal.pgen.0020183. [PubMed] 48. Oh SW, Mukhopadhyay A, Svrzikapa N, Jiang F, Davis RJ, et al. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci U S A. 2005;102:4494–4499. [PubMed] 49. Helfand SL, Blake KJ, Rogina B, Stracks MD, Centurion A, et al. Temporal patterns of gene expression in the antenna of the adult Drosophila melanogaster. Genetics. 1995;140:549–555. [PubMed] 50. Yu H, Larsen PL. DAF-16-dependent and independent expression targets of DAF-2 insulin receptor-like pathway in Caenorhabditis elegans include FKBPs. J Mol Biol. 2001;314:1017–1028. [PubMed] 51. McElwee JJ, Schuster E, Blanc E, Thomas JH, Gems D. Shared transcriptional signature in Caenorhabditis elegans Dauer larvae and long-lived daf-2 mutants implicates detoxification system in longevity assurance. J Biol Chem. 2004;279:44533–44543. [PubMed] 52. Oh SW, Mukhopadhyay A, Dixit BL, Raha T, Green MR, et al. Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nat Genet. 2006;38:251–257. [PubMed] 53. Kim SK. Common aging pathways in worms, flies, mice and humans. J Exp Biol. 2007;210:1607–1612. [PubMed] 54. Sonnichsen B, Koski LB, Walsh A, Marschall P, Neumann B, et al. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature. 2005;434:462–469. [PubMed] 55. Simmer F, Moorman C, van der Linden AM, Kuijk E, van den Berghe PV, et al. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 2003;1:e12. doi:10.1371/journal.pbio.0000012. [PubMed] 56. Kamath RS, Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods. 2003;30:313–321. [PubMed] 57. Lithgow GJ, Walker GA. Stress resistance as a determinate of C. elegans lifespan. Mech Ageing Dev. 2002;123:765–771. [PubMed] 58. Hansen M, Chandra A, Mitic L, Onken B, Driscoll M, et al. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet. 2008;4:e24. doi:10.1371/journal.pgen.0040024. [PubMed] 59. Lee H, Cho JS, Lambacher N, Lee J, Lee SJ, et al. The Caenorhabditis elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and is required for resistance to oxidative stress and for normal motility and foraging behavior. J Biol Chem. 2008;283:14988–14993. [PubMed] 60. Hansen M, Taubert S, Crawford D, Libina N, Lee SJ, et al. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell. 2007;6:95–110. [PubMed] 61. Henderson ST, Bonafe M, Johnson TE. daf-16 protects the nematode Caenorhabditis elegans during food deprivation. J Gerontol A Biol Sci Med Sci. 2006;61:444–460. [PubMed] 62. Carriere A, Ray H, Blenis J, Roux PP. The RSK factors of activating the Ras/MAPK signaling cascade. Front Biosci. 2008;13:4258–4275. [PubMed] 63. Sundaram MV. RTK/Ras/MAPK signaling. 2006. WormBook 1–19. 64. Lee MH, Hook B, Pan G, Kershner AM, Merritt C, et al. Conserved regulation of MAP kinase expression by PUF RNA-binding proteins. PLoS Genet. 2007;3:e233. doi:10.1371/journal.pgen.0030233. [PubMed] 65. Gems D, McElwee JJ. Broad spectrum detoxification: the major longevity assurance process regulated by insulin/IGF-1 signaling? Mech Ageing Dev. 2005;126:381–387. [PubMed] 66. Ayyadevara S, Engle MR, Singh SP, Dandapat A, Lichti CF, et al. Lifespan and stress resistance of Caenorhabditis elegans are increased by expression of glutathione transferases capable of metabolizing the lipid peroxidation product 4-hydroxynonenal. Aging Cell. 2005;4:257–271. [PubMed] 67. McElwee JJ, Schuster E, Blanc E, Piper MD, Thomas JH, et al. Evolutionary conservation of regulated longevity assurance mechanisms. Genome Biol. 2007;8:R132. [PubMed] 68. Kondo M, Yanase S, Ishii T, Hartman PS, Matsumoto K, et al. The p38 signal transduction pathway participates in the oxidative stress-mediated translocation of DAF-16 to Caenorhabditis elegans nuclei. Mech Ageing Dev. 2005;126:642–647. [PubMed] 69. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest. 2006;116:2464–2472. [PubMed] 70. An JH, Blackwell TK. SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev. 2003;17:1882–1893. [PubMed] 71. Tullet JM, Hertweck M, An JH, Baker J, Hwang JY, et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell. 2008;132:1025–1038. [PubMed] 72. Bishop NA, Guarente L. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature. 2007;447:545–549. [PubMed] 73. Roggo L, Bernard V, Kovacs AL, Rose AM, Savoy F, et al. Membrane transport in Caenorhabditis elegans: an essential role for VPS34 at the nuclear membrane. EMBO J. 2002;21:1673–1683. [PubMed] 74. Nanji M, Hopper N, Gems D. LET-60 RAS modulates effects of insulin/IGF-1 signaling on development and aging in Caenorhabditis elegans. Aging Cell. 2005;4:235–245. [PubMed] 75. Panowski SH, Wolff S, Aguilaniu H, Durieux J, Dillin A. PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature. 2007;447:550–555. [PubMed] 76. Samuelson A, Carr C, Ruvkun G. Gene activities that mediate increased life span of C. elegans insulin-like signaling mutants. Genes Dev. 2007;21:2976–2994. [PubMed] 77. Berdichevsky A, Viswanathan M, Horvitz HR, Guarente L. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell. 2006;125:1165–1177. [PubMed] 78. Wang Y, Tissenbaum HA. Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO. Mech Ageing Dev. 2006;127:48–56. [PubMed] 79. Klass M, Hirsh D. Non-ageing developmental variant of Caenorhabditis elegans. 260, 523–525. Nature. 1976;260:523–525. [PubMed] 80. Cherkasova V, Ayyadevara S, Egilmez N, Shmookler Reis RJ. Diverse Caenorhabditis elegans genes that are upregulated in dauer larvae also show elevated transcript levels in long-lived, aged, or starved adults. J Mol Biol. 2000;300:433–448. [PubMed] 81. Kenyon C, Murphy CT. Enrichment of regulatory motifs upstream of predicted DAF-16 targets. Nat Genet. 2006;38:397–398. [PubMed] 82. Lamitina ST, Strange K. Transcriptional targets of DAF-16 insulin signaling pathway protect C. elegans from extreme hypertonic stress. Am J Physiol Cell Physiol. 2005;288:C467–C474. [PubMed] 83. Jenkins NL, McColl G, Lithgow GJ. Fitness cost of extended lifespan in Caenorhabditis elegans. Proc Biol Sci. 2004;271:2523–2526. [PubMed] 84. McColl G, Jenkins NL, Walker DW, Lithgow GJ. Testing evolutionary theories of aging. Ann N Y Acad Sci. 2000;908:319–320. [PubMed] 85. Castillo SS, Brognard J, Petukhov PA, Zhang C, Tsurutani J, et al. Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues. Cancer Res. 2004;64:2782–2792. [PubMed] 86. Malone EA, Inoue T, Thomas JH. Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics. 1996;143:1193–1205. [PubMed] 87. Murphy CT, Lee SJ, Kenyon C. Tissue entrainment by feedback regulation of insulin gene expression in the endoderm of Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2007;104:19046–19050. [PubMed] 88. Ebert RH, Cherkasova VA, Dennis RA, Wu JH, Ruggles S, et al. Longevity-determining genes in Caenorhabditis elegans: chromosomal mapping of multiple noninteractive loci. Genetics. 1993;135:1003–1010. [PubMed] 89. Shmookler Reis RJ, Kang P, Ayyadevara S. Quantitative trait loci define genes and pathways underlying genetic variation in longevity. Exp Gerontol. 2007;41:1046–1054. [PubMed] 90. Ayyadevara S, Ayyadevera R, Hou S, Thaden JJ, Shmookler Reis RJ. Genetic mapping of quantitative trait loci governing longevity of Caenorhabditis elegans in recombinant-inbred progeny of a Bergerac-BO x RC301 interstrain cross. Genetics. 2001;157:655–666. [PubMed] 91. Ayyadevara S, Ayyadevera R, Vertino A, Galecki A, Thaden JJ, et al. Genetic loci modulating fitenss and life span in Caenorhabditis elegans: Categorical trait interval mapping in CL2a×Bergerac-BO recombinant-inbred worms. Genetics. 2003;163:557–570. [PubMed] 92. Sulston J, Hodgkin J. Methods. In: Wood WB, editor. The nematode Caenorhabditis elegans. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press; 1988. 93. Singh SP, Chen T, Chen L, Mei N, McLain E, et al. Mutagenic effects of 4-hydroxynonenal triacetate, a chemically protected form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y/Tk+/− mouse lymphoma cells. J Pharmacol Exp Ther. 2005;313:855–861. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Nature. 1981 Apr 23; 290(5808):668-71.
[Nature. 1981]Genetics. 1995 Dec; 141(4):1399-406.
[Genetics. 1995]Cell. 2005 Feb 25; 120(4):449-60.
[Cell. 2005]Genetics. 1988 Jan; 118(1):75-86.
[Genetics. 1988]Genetics. 1998 Feb; 148(2):703-17.
[Genetics. 1998]Genes Dev. 1999 Jun 1; 13(11):1438-52.
[Genes Dev. 1999]Biochem Biophys Res Commun. 1993 Aug 31; 195(1):104-12.
[Biochem Biophys Res Commun. 1993]Science. 1997 Jul 25; 277(5325):567-70.
[Science. 1997]Ann Diagn Pathol. 2008 Apr; 12(2):153-60.
[Ann Diagn Pathol. 2008]BMC Dev Biol. 2006 Oct 4; 6():45.
[BMC Dev Biol. 2006]Dev Cell. 2004 Apr; 6(4):577-88.
[Dev Cell. 2004]Nature. 2003 Jul 17; 424(6946):277-83.
[Nature. 2003]Exp Gerontol. 2006 Oct; 41(10):910-21.
[Exp Gerontol. 2006]Nature. 1981 Apr 23; 290(5808):668-71.
[Nature. 1981]Genetics. 1995 Dec; 141(4):1399-406.
[Genetics. 1995]Nature. 1993 Dec 2; 366(6454):461-4.
[Nature. 1993]Genetics. 1998 Sep; 150(1):129-55.
[Genetics. 1998]Mech Ageing Dev. 1983 Jul-Aug; 22(3-4):279-86.
[Mech Ageing Dev. 1983]Cell. 2005 Feb 25; 120(4):449-60.
[Cell. 2005]Science. 1997 Jul 25; 277(5325):567-70.
[Science. 1997]Biochem Soc Trans. 2006 Nov; 34(Pt 5):647-62.
[Biochem Soc Trans. 2006]Genetics. 2006 Sep; 174(1):309-16.
[Genetics. 2006]BMC Biol. 2006 Feb 3; 4():1.
[BMC Biol. 2006]Genetics. 1988 Jan; 118(1):75-86.
[Genetics. 1988]J Gerontol. 1988 Jul; 43(4):B102-9.
[J Gerontol. 1988]Science. 1990 Aug 24; 249(4971):908-12.
[Science. 1990]Aging Cell. 2008 Jan; 7(1):13-22.
[Aging Cell. 2008]Science. 1997 Jul 25; 277(5325):567-70.
[Science. 1997]Biochem Soc Trans. 2006 Nov; 34(Pt 5):647-62.
[Biochem Soc Trans. 2006]Cell. 2006 Mar 10; 124(5):1039-53.
[Cell. 2006]Nature. 2001 Mar 8; 410(6825):154-5.
[Nature. 2001]Mech Ageing Dev. 2006 Sep; 127(9):741-7.
[Mech Ageing Dev. 2006]Proc Natl Acad Sci U S A. 1999 Jun 22; 96(13):7427-32.
[Proc Natl Acad Sci U S A. 1999]Genes Dev. 2001 Mar 15; 15(6):672-86.
[Genes Dev. 2001]Biochem Biophys Res Commun. 2000 Jul 5; 273(2):431-6.
[Biochem Biophys Res Commun. 2000]Exp Gerontol. 2006 Oct; 41(10):910-21.
[Exp Gerontol. 2006]Crit Rev Biochem Mol Biol. 2005 May-Jun; 40(3):129-54.
[Crit Rev Biochem Mol Biol. 2005]J Biol Chem. 2002 Dec 20; 277(51):49591-7.
[J Biol Chem. 2002]Mol Cell Biol. 2007 May; 27(10):3569-77.
[Mol Cell Biol. 2007]Curr Biol. 2007 Oct 9; 17(19):1646-56.
[Curr Biol. 2007]Genes Dev. 2004 Dec 15; 18(24):3004-9.
[Genes Dev. 2004]Aging Cell. 2006 Apr; 5(2):119-26.
[Aging Cell. 2006]Curr Biol. 2007 Oct 9; 17(19):1635-45.
[Curr Biol. 2007]Curr Biol. 2007 Oct 9; 17(19):1646-56.
[Curr Biol. 2007]Aging Cell. 2006 Apr; 5(2):119-26.
[Aging Cell. 2006]PLoS Genet. 2006 Nov 10; 2(11):e183.
[PLoS Genet. 2006]Proc Natl Acad Sci U S A. 2005 Mar 22; 102(12):4494-9.
[Proc Natl Acad Sci U S A. 2005]Genetics. 1995 Jun; 140(2):549-55.
[Genetics. 1995]J Mol Biol. 2001 Dec 14; 314(5):1017-28.
[J Mol Biol. 2001]Nature. 2003 Jul 17; 424(6946):277-83.
[Nature. 2003]Exp Gerontol. 2006 Oct; 41(10):910-21.
[Exp Gerontol. 2006]J Biol Chem. 2004 Oct 22; 279(43):44533-43.
[J Biol Chem. 2004]J Exp Biol. 2007 May; 210(Pt 9):1607-12.
[J Exp Biol. 2007]Genetics. 1998 Feb; 148(2):703-17.
[Genetics. 1998]Nature. 1996 Aug 8; 382(6591):536-9.
[Nature. 1996]Aging Cell. 2008 Jan; 7(1):13-22.
[Aging Cell. 2008]Nature. 2005 Mar 24; 434(7032):462-9.
[Nature. 2005]Methods. 2003 Aug; 30(4):313-21.
[Methods. 2003]Mech Ageing Dev. 2002 Apr; 123(7):765-71.
[Mech Ageing Dev. 2002]Aging Cell. 2008 Jan; 7(1):13-22.
[Aging Cell. 2008]Methods. 2003 Aug; 30(4):313-21.
[Methods. 2003]Genetics. 1998 Feb; 148(2):703-17.
[Genetics. 1998]Genes Dev. 1998 Aug 15; 12(16):2488-98.
[Genes Dev. 1998]Nature. 1996 Aug 8; 382(6591):536-9.
[Nature. 1996]Aging Cell. 2008 Jan; 7(1):13-22.
[Aging Cell. 2008]Curr Biol. 2007 Oct 9; 17(19):1646-56.
[Curr Biol. 2007]Genes Dev. 2004 Dec 15; 18(24):3004-9.
[Genes Dev. 2004]Curr Biol. 2007 Oct 9; 17(19):1635-45.
[Curr Biol. 2007]PLoS Genet. 2006 Nov 10; 2(11):e183.
[PLoS Genet. 2006]Curr Biol. 2007 Oct 9; 17(19):1646-56.
[Curr Biol. 2007]PLoS Genet. 2008 Feb; 4(2):e24.
[PLoS Genet. 2008]J Biol Chem. 2008 May 30; 283(22):14988-93.
[J Biol Chem. 2008]Aging Cell. 2007 Feb; 6(1):95-110.
[Aging Cell. 2007]Front Biosci. 2008 May 1; 13():4258-75.
[Front Biosci. 2008]PLoS Genet. 2007 Dec 28; 3(12):e233.
[PLoS Genet. 2007]Mech Ageing Dev. 2005 Mar; 126(3):381-7.
[Mech Ageing Dev. 2005]Aging Cell. 2005 Oct; 4(5):257-71.
[Aging Cell. 2005]Genome Biol. 2007; 8(7):R132.
[Genome Biol. 2007]BMC Dev Biol. 2006 Oct 4; 6():45.
[BMC Dev Biol. 2006]Curr Biol. 2007 Oct 9; 17(19):1646-56.
[Curr Biol. 2007]PLoS Genet. 2006 Nov 10; 2(11):e183.
[PLoS Genet. 2006]Mech Ageing Dev. 2005 Jun-Jul; 126(6-7):642-7.
[Mech Ageing Dev. 2005]J Clin Invest. 2006 Sep; 116(9):2464-72.
[J Clin Invest. 2006]Genes Dev. 2003 Aug 1; 17(15):1882-93.
[Genes Dev. 2003]Nature. 2007 May 31; 447(7144):545-9.
[Nature. 2007]EMBO J. 2002 Apr 2; 21(7):1673-83.
[EMBO J. 2002]PLoS Genet. 2008 Feb; 4(2):e24.
[PLoS Genet. 2008]Aging Cell. 2005 Oct; 4(5):235-45.
[Aging Cell. 2005]Nature. 1981 Apr 23; 290(5808):668-71.
[Nature. 1981]Nature. 1976 Apr 8; 260(5551):523-5.
[Nature. 1976]J Mol Biol. 2000 Jul 14; 300(3):433-48.
[J Mol Biol. 2000]Genetics. 1995 Apr; 139(4):1567-83.
[Genetics. 1995]Nature. 2003 Jul 17; 424(6946):277-83.
[Nature. 2003]Aging Cell. 2003 Apr; 2(2):111-21.
[Aging Cell. 2003]Nature. 1996 Aug 8; 382(6591):536-9.
[Nature. 1996]Nat Genet. 2006 Feb; 38(2):251-7.
[Nat Genet. 2006]Proc Biol Sci. 2004 Dec 7; 271(1556):2523-6.
[Proc Biol Sci. 2004]Ann N Y Acad Sci. 2000 Jun; 908():319-20.
[Ann N Y Acad Sci. 2000]Genes Dev. 2001 Mar 15; 15(6):672-86.
[Genes Dev. 2001]Cell. 2006 Jun 16; 125(6):1165-77.
[Cell. 2006]Ann Diagn Pathol. 2008 Apr; 12(2):153-60.
[Ann Diagn Pathol. 2008]Biochem Soc Trans. 2006 Nov; 34(Pt 5):647-62.
[Biochem Soc Trans. 2006]Cancer Res. 2004 Apr 15; 64(8):2782-92.
[Cancer Res. 2004]Cell. 2005 Feb 25; 120(4):449-60.
[Cell. 2005]Nature. 1981 Apr 23; 290(5808):668-71.
[Nature. 1981]Genetics. 1996 Jul; 143(3):1193-205.
[Genetics. 1996]Proc Natl Acad Sci U S A. 2007 Nov 27; 104(48):19046-50.
[Proc Natl Acad Sci U S A. 2007]Nature. 2003 Jul 17; 424(6946):277-83.
[Nature. 2003]Biochem Biophys Res Commun. 1993 Aug 31; 195(1):104-12.
[Biochem Biophys Res Commun. 1993]Genetics. 1993 Dec; 135(4):1003-10.
[Genetics. 1993]Genetics. 2001 Feb; 157(2):655-66.
[Genetics. 2001]Genetics. 2003 Feb; 163(2):557-70.
[Genetics. 2003]Methods. 2003 Aug; 30(4):313-21.
[Methods. 2003]J Pharmacol Exp Ther. 2005 May; 313(2):855-61.
[J Pharmacol Exp Ther. 2005]Aging Cell. 2008 Jan; 7(1):13-22.
[Aging Cell. 2008]Exp Gerontol. 2006 Oct; 41(10):1046-54.
[Exp Gerontol. 2006]